| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/13/2011 | WO2011005645A1 Polymorph of [4,6-bis(dimethylamino)-2-(4-{[4-(trifluoromethyl)benzoyl]amino}benzyl)pyrimidin-5-yl] |
| 01/13/2011 | WO2011005306A2 Production of and uses for decellularized lung tissue |
| 01/13/2011 | WO2011004882A1 Acid pump antagonist for treatment of diseases associated with abnormal gastrointestinal movement |
| 01/13/2011 | WO2011003925A1 Humanised antibodies to toll-like receptor 2 and uses thereof |
| 01/13/2011 | WO2011003221A1 A medicine composition for treating bronchial asthma and preparative method thereof |
| 01/13/2011 | US20110009631 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
| 01/13/2011 | US20110009626 Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 01/13/2011 | US20110009625 Novel compounds |
| 01/13/2011 | US20110009482 Methods of treating copd |
| 01/13/2011 | US20110009452 Hydroxyalkanyl amides as modulators of chemokine receptor activity |
| 01/13/2011 | US20110009448 Compound |
| 01/13/2011 | US20110009444 N-azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009439 Indene derivatives as pharmaceutical agents |
| 01/13/2011 | US20110009435 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions |
| 01/13/2011 | US20110009434 Crystals of isopropyl ester of n-(2,6-dichlorobenzoyl)-4-[6-(methylamino)methyl -1-methyl-2,4-dioxo-1,4-dihydroquinazoline-3(2h)-yl]-l- phenylalanine hydrochloride, production method thereof and use thereof |
| 01/13/2011 | US20110009432 Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof |
| 01/13/2011 | US20110009430 Methods and compositions for treating pain |
| 01/13/2011 | US20110009429 Heterocyclic compounds as inhibitors of cxcr2 |
| 01/13/2011 | US20110009426 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as urotensin ii receptor antagonists |
| 01/13/2011 | US20110009396 Tricyclic compounds for the treatment of inflammatory disorders |
| 01/13/2011 | US20110009393 Novel Soluble 1,4 Benzodiazepine Compounds and Stable Salts Thereof |
| 01/13/2011 | US20110009390 2-oxo-2- (2-phenyl-5,6,7,8-tetrahydro-indolizin-3-yl) -acetamide derivatives and related compounds as antifungal agents |
| 01/13/2011 | US20110009386 Furo[3, 2-b] pyrr0l-3-0nes as cathespin s inhibitors |
| 01/13/2011 | US20110009385 Compounds |
| 01/13/2011 | US20110009382 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles |
| 01/13/2011 | US20110009377 Azetidine derivatives, their preparation and their application in therapy |
| 01/13/2011 | US20110009367 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 01/13/2011 | US20110009365 Derivatives of indole-2-carboxamides and of azaindole-2-carboxamides substituted with a silanyl group, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009364 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009361 Design and selection of medicaments that modulate the function and activity of interleukin 13 |
| 01/13/2011 | US20110009351 Screening assay to identify correctors of protein trafficking defects |
| 01/13/2011 | US20110008455 Crosslinked Protein Nanocrystals, Crosslinked Protein Nanoaggregates and Method of Preparation Thereof |
| 01/13/2011 | US20110008453 Stable Corticosteroid Nanoparticulate Formulations And Methods For The Making And Use Thereof |
| 01/13/2011 | US20110008435 Nanoparticulate and Controlled Release Compositions Comprising Aryl-Heterocyclic Compounds |
| 01/13/2011 | US20110008419 Vaccine Against Streptococcus Pneumoniae |
| 01/13/2011 | US20110008366 Inhibition of versican with sirna and other molecules |
| 01/13/2011 | US20110008357 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 01/13/2011 | US20110008352 Toll-Like Receptor 3 Antagonists |
| 01/13/2011 | US20110008349 Hypoxia Induced Mitogenic Factor |
| 01/13/2011 | US20110008345 Antigen-binding constructs |
| 01/13/2011 | US20110008338 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008337 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008336 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008326 Binding agents directed against il-4 receptor for the treatment of tumors, inflammatory and immunological disorders |
| 01/13/2011 | US20110008325 Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid Prepared from a Unit Dose Suspension |
| 01/13/2011 | US20110008286 Novel proline substituted cyclosporin analogues |
| 01/13/2011 | US20110008285 Novel cyclosporin analogues |
| 01/13/2011 | US20110008284 Novel clyclosporin analogues |
| 01/13/2011 | US20110008269 Compositions and Methods Which Modulate G-Protein Signaling for the Treatment of Inflammatory Disorders such as Asthma and Allergic Conjunctivitis |
| 01/13/2011 | US20110008268 Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity |
| 01/13/2011 | US20110008259 Modulators of cystic fibrosis transmembrane conductance regulator |
| 01/13/2011 | US20110008258 Methods relating to breathing disorders |
| 01/13/2011 | US20110008251 Methods for Generating Stably Linked Complexes Composed of Homodimers, Homotetramers or Dimers of Dimers and Uses |
| 01/13/2011 | US20110008250 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008248 Peptide Antagonists of TGF-Beta Family Members and Therapeutic Uses Thereof |
| 01/13/2011 | US20110005947 Inhibitors of jak |
| 01/13/2011 | US20110005518 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics |
| 01/13/2011 | DE102009031274A1 Liposomen zur pulmonalen Applikation Liposomes for pulmonary administration |
| 01/13/2011 | CA2767257A1 Stable crystalline polymorphs of the dipotassium salt of (s)-2-{4-[2-(2,4-diamino-quinazolin-6-yl)-ethyl]-benzoylamino}-4-methylene-penta nedioic acid |
| 01/13/2011 | CA2766996A1 Humanised antibodies to toll-like receptor 2 and uses thereof |
| 01/13/2011 | CA2765529A1 Acid pump antagonist for treatment of diseases involved in abnormal gastrointestinal motility |
| 01/12/2011 | EP2272869A2 Angiopoietin-2 specific binding agents |
| 01/12/2011 | EP2272854A1 Novel glycolipid and use thereof |
| 01/12/2011 | EP2272844A1 Five-membered ring compound |
| 01/12/2011 | EP2272841A1 Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 01/12/2011 | EP2272835A1 Novel five-membered ring compound |
| 01/12/2011 | EP2272832A1 Phenylpropionic acid derivative and use thereof |
| 01/12/2011 | EP2272513A1 Pharmaceutical compositions for treating cancer |
| 01/12/2011 | EP2272512A1 Pharmaceutical compositions for treating cancer |
| 01/12/2011 | EP2272508A2 Pharmaceutical Formulations for Dry Powder Inhalers |
| 01/12/2011 | EP2271643A1 Compounds |
| 01/12/2011 | EP2271640A2 Piperidine derivatives as cgrp receptor antagonists |
| 01/12/2011 | EP2271334A2 Methods of treating fibrotic disorders |
| 01/12/2011 | EP2129368B1 Combination for use in the treatment of inflammatory disorders |
| 01/12/2011 | EP1490357B1 Toluene solvate of darifenacin |
| 01/12/2011 | EP1439863B1 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 01/12/2011 | EP1402266B1 Reducing RISK OF COMPLICATIONS OF PREMATURITY |
| 01/12/2011 | CN201701514U Tablet capsule containing roxithromycin tablets and ambroxol hydrochloride tablets |
| 01/12/2011 | CN201701513U Tablet capsule filled with cefalexin tablets and ambroxol hydrochloride tablets |
| 01/12/2011 | CN201701512U Tablets capsule containing loratadine tablets and ambroxol hydrochloride tablets |
| 01/12/2011 | CN201701511U Tablet capsule filled with amoxicillin tablets and ambroxol hydrochloride tablets |
| 01/12/2011 | CN201701510U Tablet capsule filled with salbutamol sulfate tablet and ambroxol hydrochloride tablet |
| 01/12/2011 | CN1943781B Orally administered peptides to ameliorate atherosclerosis |
| 01/12/2011 | CN101945885A Steroid derivatives acting as glucocorticosteroid receptor agonists |
| 01/12/2011 | CN101945851A Peptidyl nitriles and use thereof as dipeptidyl peptidase i inhibitors |
| 01/12/2011 | CN101945659A Adrenomedullin production enhancer |
| 01/12/2011 | CN101942441A Structure and application of siRNA for suppressing proliferation and metastasis of human lung cancer cells |
| 01/12/2011 | CN101940773A Chinese medicinal herb for treating chronic bronchitis |
| 01/12/2011 | CN101940760A Traditional Chinese medicine for treating chronic tracheitis |
| 01/12/2011 | CN101940749A Novel antitussive spray and preparation process thereof |
| 01/12/2011 | CN101940748A Chinese medicinal paste |
| 01/12/2011 | CN101940728A Chinese medicinal preparation for treating pneumonia |
| 01/12/2011 | CN101940707A Traditional Chinese medicine for treating tracheitis |
| 01/12/2011 | CN101940704A Compound combination medicament for treating asthma and preparation method thereof |
| 01/12/2011 | CN101940653A Chinese medicament for treating viral influenza |
| 01/12/2011 | CN101940638A Orally-taking Chinese medicinal preparation for treating infection of upper respiratory tract |
| 01/12/2011 | CN101940598A Preparation method of Huang children paracetamol-particles |
| 01/12/2011 | CN101554446B Traditional Chinese medicine composition for treating chronic pharyngitis |
| 01/12/2011 | CN101548955B Florfenicol lung targeting microspheres for animals and method for preparing same |
| 01/12/2011 | CN101507748B External medicine liquor for treating common cold and preparation method thereof |